The medical economic effects of the Pneumococcal vaccine in the elderly.

The medical economic effects of the Pneumococcal vaccine in the elderly. - Pneumococcal vaccination in the elderly.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001681

Enrollment

200

Registered

2009-03-01

Start date

2009-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired pneumonia in the elderly

Interventions

Pneumococcal vaccination without Pneumococcal vaccination

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who understand the purpose of this study and give informed consent.

Exclusion criteria

Exclusion criteria: 1) patients who have already received Pneumococcal vaccine. 2) patients who are receiving radiation therapy 3) patients who are given an immunosuppressive drug 4) patients who have fever 5) patients with a malignant neoplasm 6) patients with a severe disease in liver, kidney, heart, or lung 7) when the doctor decides the patient's condition is inappropriate

Design outcomes

Primary

Measure	Time frame
Incidence of pneumonia	—

Secondary

Measure	Time frame
Medical costs	—

Countries

Japan

Contacts

Public ContactHiroshi KUBO

Tohoku University School of Medicine Department of Advanced Preventive Medicine for Infectious Disease

hkubo@m.tains.tohoku.ac.jp022-717-7184

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026